Innogene Co Ltd
Innogene Co Ltd operates in Personal Care Products.
Innogene Co Ltd (344860) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, Innogene Co Ltd (344860) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Innogene Co Ltd - Net Assets Trend (None–None)
This chart illustrates how Innogene Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Innogene Co Ltd (None–None)
The table below shows the annual net assets of Innogene Co Ltd from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Innogene Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Innogene Co Ltd Competitors by Market Cap
The table below lists competitors of Innogene Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vietnam Construction JSC No. 3
VN:VC3
|
$9.53K |
|
2258
TW:2258
|
$9.53K |
|
MAENDELEO BANK PLC
DSE:MBP
|
$9.54K |
|
Nations Trust Bank PLC
CM:NTBN0000
|
$9.55K |
|
Macter International Ltd
KAR:MACTER
|
$9.53K |
|
189350
KO:189350
|
$9.52K |
|
Aurrigo International PLC
LSE:AURR
|
$9.51K |
|
CHINA SHINEWAY PHAR (C1S.SG)
STU:C1S
|
$9.51K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Innogene Co Ltd's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Innogene Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Innogene Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Innogene Co Ltd's net assets metrics with peer companies in the Personal & Household Products & Services industry.
Industry Context
- Industry: Personal & Household Products & Services
- Average net assets among peers: $84,610,558,200
- Average return on equity (ROE) among peers: -6.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Innogene Co Ltd (344860) | ₩- | N/A | N/A | $9.53K |
| Globon Co. Ltd (019660) | $23.23 Billion | 0.00% | 0.16x | $25.19 Million |
| HYUNDAI BIOLAND Co.Ltd (052260) | $121.82 Billion | 8.85% | 0.26x | $27.10 Million |
| Gentrogroup Co. Ltd. (083660) | $16.51 Billion | -46.25% | 1.01x | $3.92 Million |
| NeoPharm CO. LTD (092730) | $176.88 Billion | 13.04% | 0.09x | $57.26 Million |